Kepler Capital Markets set a €115.00 ($135.29) price objective on Merck KGaA (FRA:MRK) in a report released on Wednesday morning. The brokerage currently has a buy rating on the healthcare company’s stock.

MRK has been the topic of a number of other research reports. Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) price target on shares of Merck KGaA and gave the company a neutral rating in a report on Tuesday, September 19th. Citigroup Inc. set a €123.00 ($144.71) price target on shares of Merck KGaA and gave the company a buy rating in a report on Monday, September 25th. DZ Bank AG reaffirmed a sell rating on shares of Merck KGaA in a report on Tuesday, July 18th. Warburg Research set a €116.00 ($136.47) price target on shares of Merck KGaA and gave the company a neutral rating in a report on Friday, July 7th. Finally, Commerzbank Ag set a €109.00 ($128.24) price target on shares of Merck KGaA and gave the company a neutral rating in a report on Wednesday, September 6th. Thirteen investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of €109.43 ($128.75).

Shares of Merck KGaA (MRK) opened at 95.50 on Wednesday. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00. The firm has a 50-day moving average of €94.96 and a 200 day moving average of €101.83. The company has a market cap of €41.52 billion and a price-to-earnings ratio of 24.90.

ILLEGAL ACTIVITY NOTICE: “Kepler Capital Markets Reiterates “€115.00” Price Target for Merck KGaA (MRK)” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/kepler-capital-markets-reiterates-115-00-price-target-for-merck-kgaa-mrk/1616531.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.